Researchers from Freiburg have developed a sensor platform that quantifies antibiotics in human blood within minutes
A team of researchers from the University of Freiburg has developed a system inspired by biology that can detect several different antibiotics in human blood or other fluids at the same time. This biosensor system could be used for medical diagnostics in the future, especially for point-of-care testing in doctors’ practices, on house calls and in pharmacies, as well as in environmental and food safety testing. The researchers focused their study on the antibiotics tetracycline and streptogramin in human blood. “The analysis takes only 10 minutes, from sample to result,” said the microsystems engineer Dr. Can Dincer, who is the head of the research team: “Our study was about demonstrating the applicability of the platform.” The researchers have recently published their results in Analytical Chemistry. Based on these findings, the group is currently working on developing a method to determine how quickly the human body breaks down antibiotics, thus enabling the dosage of medications to be adjusted to each patient. “This technology could pave the way for personalized antibiotic treatments in the future,” Dincer said.
The all-too-frequent use of antibiotics in human and veterinary medicine causes pathogens to develop resistance. Multidrug resistant bacteria are the reason for an increasing number of life-threatening infections that are difficult to treat with medications available today. In this context, biosensors have so much potential in research, since they are inexpensive and easy to work with. It is expected that biosensors can be employed to customize antibiotic treatments to fit each patient`s requirements, thereby decreasing the development of resistant bacteria in the future.
The electrochemical biosensor platform was developed by Prof. Dr. Gerald Urban’s research group. It works with extremely small amounts of liquid. “The major advantage of this system is that we can measure up to eight different substances at the same time, quickly and simply,” Dincer said. The researchers combined their chip technology with a method developed earlier by the bioengineering expert Prof. Dr. Wilfried Weber, also from the University of Freiburg. The method is based on a naturally occurring sensor protein in resistant bacteria to recognize antibiotics and activate their defence mechanisms. These bacterial sensors react quickly, sensitively and specifically to antibiotics, which makes them ideal for analytical testing. Essentially, the bacteria are providing the researchers with a tool that can be applied to fight them back in the long-run.
Learn more: Personalized antibiotic treatment
The Latest on: Personalized antibiotic treatment
via Google News
The Latest on: Personalized antibiotic treatment
- VYNE Therapeutics Inc. (VYNE) Q1 2021 Earnings Call Transcripton May 6, 2021 at 10:01 pm
Q1 2021 Earnings CallMay 06, 2021, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, and welcome to the VYNE Therapeutics ...
- Knee Arthrodesis in the Treatment of Failed Total Knee Replacementon May 2, 2021 at 5:00 pm
In addition, 6 repeat arthrodeses with intramedullary nail fixation were performed for the treatment of nonunions ... A PMMA cement-antibiotic spacer mixed with tobramycin and vancomycin was ...
- Antibiotics Drug Market Size Estimated to Reach $45.18 Billion by 2025on April 30, 2021 at 2:02 pm
The Antibiotics Drug Market size is estimated to reach 45 18 Bn by 2025 growing at a CAGR of 3 23 during the forecast period 2020 2025 An antibiotic is an anti microbial substance that is used to ...
- Drug development platform could provide flexible, rapid and targeted antimicrobialson April 21, 2021 at 8:23 am
Unfortunately, developing custom drugs as countermeasures is often ... of approach—aided in part by recent over prescription of antibiotics by doctors. FAST, on the other hand, can be used ...
- Drug development platform could provide flexible, rapid and targeted antimicrobialson April 20, 2021 at 2:08 pm
Unfortunately, developing custom drugs as countermeasures is often ... to pandemics and how we approach increasing cases of antibiotic resistance globally. The Facile Accelerated Specific ...
- Drug development platform could provide flexible, rapid and targeted antimicrobialson April 19, 2021 at 5:00 pm
The work could change the way we respond to pandemics and how we approach increasing cases of antibiotic resistance ... Unfortunately, developing custom drugs as countermeasures is often a slow ...
- Nanosponges Absorb Pore-forming Toxins from Snakes and Antibiotic-Resistant Bacteria (w/video)on April 15, 2021 at 5:00 pm
Unlike most other antitoxins, the nanosponges work regardless of the molecular structure of the toxin and thus do not need to be custom synthesized ... of their treatment, the researchers ...
- Optimizing AAV and Lentiviral Vector Developmenton April 15, 2021 at 6:49 am
They may also serve other functions, such as imparting antibiotic resistance ... the lentivirus expression plasmid (pALD-LentiEGFP) for custom production, replacing the EGFP sequence.
- ACP best practice advice: Shorter course of antibiotics may be appropriate for some common infectionon April 5, 2021 at 2:05 pm
Specifically, ACP recommends the following: COPD Exacerbation and Acute Uncomplicated Bronchitis: Clinicians should limit antibiotic treatment ... @acponline.org. A personalized patient navigation ...
via Bing News